Viewing data from:

METHIMAZOLE

ANDA

METHIMAZOLE | A202068 | RISING PHARMA HOLDINGS INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.1253

per ea

Lowest NADAC/Unit

$0.0722

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64980026501METHIMAZOLE 10 MG TABLET	$0.1253	EA	Generic	—	2026-06-17
64980026401METHIMAZOLE 5 MG TABLET	$0.0722	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain6 active DMFs

6 active API suppliers hold Drug Master Files for this ingredient.

CU CHEMIE UETIKON GMBHMETHIMAZOLE

DMF 62891986

MACLEODS PHARMACEUTICALS LTDMETHIMAZOLE

DMF 299972015

MAITHRI DRUGS PRIVATE LTDMETHIMAZOLE USP

DMF 366432021

KALINTIS HEALTHCARE PVT LTDMETHIMAZOLE USP

DMF 403722024

SUZHOU RYWAY BIOTECH CO LTDMETHIMAZOLE

DMF 409022024

APISYN HEALTHCARE PRIVATE LTDMETHIMAZOLE USP

DMF 436982026

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 7, 2012

No patent or exclusivity listings for this strength.

#002 — 10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 7, 2012